Oreola Donini
Chief Tech/Sci/R&D Officer chez SOLIGENIX, INC.
Fortune : - $ au 31/03/2024
Profil
Oreola Donini is currently the Chief Scientific Officer & Senior Vice President at Soligenix, Inc. Prior to this, Oreola held the position of Senior Director-Preclinical Research & Development at Inimex Pharmaceuticals, Inc. from 2007 to 2013.
Oreola also worked as a Principal at Kinetek Pharmaceuticals, Inc. Oreola's former roles also include Vice President-Research & Development at ESSA Pharma, Inc. from 2012 to 2013.
Oreola obtained a doctorate degree from Queen's University and a graduate degree from The University of California, San Francisco.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SOLIGENIX, INC.
-.--% | 08/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Oreola Donini
| Sociétés | Poste | Début |
|---|---|---|
| SOLIGENIX, INC. | Chief Tech/Sci/R&D Officer | 15/08/2013 |
Anciens postes connus de Oreola Donini
| Sociétés | Poste | Fin |
|---|---|---|
Inimex Pharmaceuticals, Inc.
 Inimex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inimex Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of Innate Defense Regulators (IDRs). IDRs are novel drugs that selectively trigger the body's innate defenses, protecting against antibiotic-resistant infections and controlling inflammation. The company was founded in 2001 and is headquartered in Vancouver, Canada. | Chief Tech/Sci/R&D Officer | 01/01/2013 |
| ESSA PHARMA INC. | Chief Tech/Sci/R&D Officer | 01/01/2013 |
| Kinetek Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
Formation de Oreola Donini
| Queen's University | Doctorate Degree |
| The University of California, San Francisco | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SOLIGENIX, INC. | Health Technology |
| ESSA PHARMA INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Inimex Pharmaceuticals, Inc.
Inimex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Inimex Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of Innate Defense Regulators (IDRs). IDRs are novel drugs that selectively trigger the body's innate defenses, protecting against antibiotic-resistant infections and controlling inflammation. The company was founded in 2001 and is headquartered in Vancouver, Canada. | Health Technology |
| Kinetek Pharmaceuticals, Inc. | Health Technology |
